Cargando…
The management and outcome of women with post-hydatidiform mole ‘low-risk’ gestational trophoblastic neoplasia, but hCG levels in excess of 100 000 IU l(−1)
BACKGROUND: Gestational trophoblastic neoplasia (GTN) after a hydatidiform mole is either treated with single- or multi-agent chemotherapy determined by a multifactorial scoring system. Women with human chorionic gonadotrophin (hCG) levels >100 000 IU l(−1) can remain within the low-risk/single-a...
Autores principales: | McGrath, S, Short, D, Harvey, R, Schmid, P, Savage, P M, Seckl, M J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2833242/ https://www.ncbi.nlm.nih.gov/pubmed/20160727 http://dx.doi.org/10.1038/sj.bjc.6605529 |
Ejemplares similares
-
Early prediction of treatment resistance in low-risk gestational trophoblastic neoplasia using population kinetic modelling of hCG measurements
por: You, B, et al.
Publicado: (2013) -
High Risk of Gestational Trophoblastic Neoplasia Development in Recurrent Hydatidiform Moles with NLRP7 Pathogenic Variations
por: Kocabey, M., et al.
Publicado: (2023) -
Vitamin D receptor expression in hydatidiform mole and gestational trophoblastic neoplasia: A cross-sectional study
por: Sasotya, RM Sonny, et al.
Publicado: (2023) -
A Case of Rapid Transformation from Hydatidiform Mole to Invasive Mole: The Importance of β-hCG (Human Chorionic Gonadotropin) Serum Levels in Follow-Up Evaluation
por: Harsono, Ali Budi, et al.
Publicado: (2021) -
Hydatidiform Mole
Publicado: (1908)